TRANSAMINASES

TRANSAMINASES was reported 59 times

TRANSAMINASES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD33-directed Immunoconjugate [EPC] 1 0.0003
1 Estrogen Receptor Antagonist [EPC] 9 0.0002
2 Antimycobacterial [EPC] 3 0.0001
3 HER2/neu Receptor Antagonist [EPC] 9 0.0001
4 Rifamycin Antibacterial [EPC] 3 0.0001
5 Aromatase Inhibitor [EPC] 9 0.0001
6 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
7 Asparagine-specific Enzyme [EPC] 1 0.0001
8 Microtubule Inhibitor [EPC] 10 0.0001
9 Vascular Endothelial Growth Factor Inhibitor [EPC] 9 0.0000
10 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
11 Intestinal Lipase Inhibitor [EPC] 1 0.0000
12 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
13 Nucleoside Metabolic Inhibitor [EPC] 10 0.0000
14 Selective T Cell Costimulation Modulator [EPC] 5 0.0000
15 Interleukin-17A Antagonist [EPC] 1 0.0000
16 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
17 Platinum-based Drug [EPC] 4 0.0000
18 Catecholamine [EPC] 1 0.0000
19 Integrin Receptor Antagonist [EPC] 1 0.0000
20 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
21 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
22 Alkylating Drug [EPC] 2 0.0000
23 Leukocyte Growth Factor [EPC] 1 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
27 Mood Stabilizer [EPC] 1 0.0000
28 Kinase Inhibitor [EPC] 2 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
30 Thalidomide Analog [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 1 0.0000
32 Proton Pump Inhibitor [EPC] 1 0.0000
33 Benzodiazepine [EPC] 1 0.0000
34 Corticosteroid [EPC] 1 0.0000